Skip to the content

MLS® M-Hi

 

Discover the MLS® M-Hi

The (r)evolution of MLS®. 

The M-Hi from ASA
 couples the renowned dual wavelength delivery of MLS® with the high peak power of 270W. With an average power of 3.6W the M-Hi offers a safe, intuitive and effective treatment option. 
No more struggling with complicated equipment or wasting time on cumbersome setups. The user-friendly M-Hi has been designed and manufactured in Italy, with clinicians like you in mind.

Are you ready to AIM-HiGHER? 

#AIM-HiGHER

 

Efficient.

Patented technology, scientifically and clinically validated.

  • M-Hi is efficient in run-time and over time, thanks to advanced internal sensors that ensure durability and stability.
  • With +100 scientific publications and +20,000 devices installed all around the world, the patented MLS® Laser Therapy is scientifically and clinically proven.

Safe.

Reliability in your hands.

  • M-Hi inherits the mechanisms of action of MLS®, evolving its technological features while delivering validated state-of-the-art protocols
  • Applying the most powerful protocol (es. osteoarthritis) in both Point-by-Point and Scan modality, M-Hi delivers the right energy mix to the target tissues through a pleasant feeling: always far from reaching the thermal damage threshold​.

Versatile.

Suitable to all clinical environments and methods, for an intensive daily use.

  • Lightweight: ergonomic, easy to handle and to operate, M-Hi is always at your side.
  • Cordless: thanks to its interchangeable batteries, M-Hi ensures hours of treatments and freedom of movement.
  • Long lasting & High performing battery: M-Hi covers the entire working day without the need for recharging (at least 20 patients per day, for an average of 10min per patient). 

Adaptive.

Focus on your patients: M-Hi automatically adapts the protocols to your needs.

Thanks to the patented system of automatic lens recognition and parameters adjustment, M-Hi adapts the protocol to ensure the desired dosage values. The tissue-targeted protocols available for all body districts are extremely easy to follow: let them guide you to immediate results.

Accurate.

No more guesswork: track the dose, objectify your therapy and replicate the results.

Dosage (J/cm2): Track the energy delivered per unit of treatment surface (J/cm2).

Evidence-based Medicine.

Safety and effectiveness of MLS® Laser Therapy are constantly proven at ASAcampus, the Joint Laboratory between ASA Research division and the Department of Biomedical and Clinical Experimental Science at the University of Florence – Italy, directed by Dr. Monica Monici.

Evidence based treatment settings for: 

    • Osteoarthritis1
    • Rheumatoid Arthritis2
    • Bursitis3
    • Sprain/Contusion4
    • Tendinopathies5
    • Myalgia/Contracture (from myofascial pain syndrome, trigger points, muscle spasms, postural or traumatic causes) 6

    From mild to moderate stages (up to 3rd grade) with high level of clinical evidence on knee, moderate on shoulder, wrist, hip, ankle, lumbar region;
    From very low to severe stages with moderate level of clinical evidence on hand;
    3From mild to severe pain with moderate level of clinical evidence on elbow, knee, ankle, toe;
    From mild to moderate injury (up to 2nd grade sprain, without complete ligament tear) with moderate level of clinical evidence on knee, ankle, wrist, finger;
    5 From mild to severe pain and disability levels with moderate level of clinical evidence on shoulder, elbow, wrist, finger, knee, ankle, foot;
    6 From mild to severe pain and disability levels with moderate/moderate-high level of clinical evidence on shoulder, cervical, lumbar and temporomandibular regions.

     

Tailored treatments.

Whether you wish to treat large areas, trigger points, intra-articular windows in close contact or at a distance, M-Hi is equipped with the optical terminal that fits your needs.

  • Ø 2 cm collimated lens - 3 cm2 target area: versatile lens suitable for any type of application.
  • Ø 5 cm collimated lens - 20 cm2 target area: homogeneous irradiation of large volumes of tissue in a short time, from contact up to 30 cm distance.
  • Ø 4 mm lens - 0.13 cm2 target area: conical light guide designed for rapid, targeted and painless laser puncture treatments.
  • Ø 8 mm lens - 0.5 cm2 target area: curved light guide ideal for treating very localised and hard-to-reach painful areas, such as facial or interdigital points.

Modular device configuration

While the trolley allows swift movements inside the clinic , the handpiece holder arm ensures precise positioning on different body targets on all patients for a fixed point use.

  • Laser source with patented pulse MLS® up to 3.6 W
  • MLS® modulation in CPW and FPW (synchronised emission of Continuous Pulsed Wave and Frequenced Pulsed Wave)
  • Peak power outside handpiece: 270 W
  • Power level from 1% to 100%
  • MLS® pulse modulation frequency from 1 to 2000 Hz in 1 Hz steps
  • Treatment time from 1” to 30’00” in steps of 1”
  • Automatic calculation of the energy emitted according to the parameters set
  • Automatic recognition of the lens and parameters adaptation
  • 52 x 55 x 106 (W x D x H) cm; 23 kg (M-Hi + trolley + arm)

ACCESSORIES PROVIDED

  • N° 2 Laser Safety Goggles
  • Unit carrying case
  • Shoulder strap for portable use
  • Lens case attachable to the shoulder strap
  • 4 lenses:
    • Ø 4 mm (0,13 cm2)
    • Ø 8 mm (0,5 cm2)
    • Ø 2 cm (3 cm2)
    • Ø 5 cm (20 cm2)

OPTIONAL ACCESSORIES

  • Trolley: with storage compartment, 4 swivel wheels and self-locking system equipped with handpiece holder arm for fixed point use featuring sphere and joints
  • Battery kit: consisting of an exclusive charger, battery and connection cable, it allows the device to be used throughout the day without the need to plug it into the mains

ALARMS AND SAFETY EQUIPMENT

  • Laser emission warning light
  • Interlock
  • Acoustic signal adjustable by the operator
  • Date and time
  • Password to operate the device
  • Language option
  • Ready to be connected to the remote Laser emission signalling device
  • Lens with target area highlighted by high efficiency red light LEDs
  • 10.1” high brightness LCD touchscreen display
  • Pre-set programs for 11 body districts
  • Programs section for laser puncture
  • Treatment images and videos
  • Possibility of customising each treatment parameter and save personal protocols
  • Treatment log to keep track of patients recovery path
  • Back-up system: a buffer battery keeps the device in stand-by mode when disconnected from the mains to allow the user to move it without having to switch it off
  • Statistics of device usage

POWER SUPPLY

  • 100-240 V AC 50/60 Hz 51-68 VA external power supply unit
  • Lithium-ion battery  (optional) 14,4V  6,9Ah; 0,5 kg

DIMENSIONS AND WEIGHT

  • 30 x 35 x 15 (W x D x H) cm; 4 kg (M-Hi)

Download the brochure

Download the M-Hi catalogue

Each year the ASAcampus (an association between ASAlaser and The University of Florence) publish 'Energy for Health', a scientific magazine focusing on the results of research and clinical studies carried out by internationally renowned researchers, doctors and specialists both in Italy and abroad.

Energy For Health 2023

Energy for Health 2022

Energy for Health 2021

Energy for Health 2020

Energy for Health 2019

Energy for Health 2018

Energy for Health 2017

Energy for Health 2016

Energy for Health 2015

Energy for Health 2014

Chow RT, David MA, Armati PJ. 830 nm laser irradiation induces varicosity formation, reduces mitochondrial membrane potential and blocks fast axonal flow in small and medium diameter rat dorsal root ganglion neurons: implications for the analgesic effects of 830 nm laser. J Peripher Nerv Syst. 2007 Mar;12(1):28-39.

Simunovic Z. Low level laser therapy with trigger points technique: a clinical study on 243 patients. J Clin Laser Med Surg. 1996 Aug;14(4):163-7.

Bjordal JM, Lopes-Martins RA, Iversen VV. A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations. Br J Sports Med. 2006 Jan;40(1):76-80; discussion 76-80.

Xavier M, David DR, de Souza RA, Arrieiro AN, Miranda H, Santana ET, Silva JA Jr, Salgado MA, Aimbire F, Albertini R. Anti-inflammatory effects of low-level light emitting diode therapy on Achilles tendinitis in rats. Lasers Surg Med. 2010 Aug;42(6):553-8.

Albertini R, Aimbire F, Villaverde AB, Silva JA Jr, Costa MS. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-induced inflammation after low level laser therapy. Inflamm Res. 2007 Jun;56(6):228-9.

Kajagar BM, Godhi AS, Pandit A, Khatri S. Efficacy of low level laser therapy on wound healing in patients with chronic diabetic foot ulcers-a randomised control trial. Indian J Surg. 2012 Oct;74(5):359-63.

Baxter GD, Liu L, Petrich S, Gisselman AS, Chapple C, Anders JJ, Tumilty S. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer. 2017 Dec 7;17(1):833.

Wigg, J. Use and response to treatment using low lovel laser therapy. Journal of Lymphoedema, 2009, Vol 4, No 2.

Medrado AR, Pugliese LS, Reis SR, Andrade ZA. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med. 2003;32(3):239-44.

Fabre HS, Navarro RL, Oltramari-Navarro PV, Oliveira RF, Pires-Oliveira DA, Andraus RA, Fuirini N, Fernandes KB. Anti-inflammatory and analgesic effects of low-level laser therapy on the postoperative healing process. J Phys Ther Sci. 2015 Jun;27(6):1645-1648.

Artés-Ribas M, Arnabat-Dominguez J, Puigdollers A. Analgesic effect of a low-level laser therapy (830 nm) in early orthodontic treatment. Lasers Med Sci. 2013 Jan;28(1):335-41.

Wang P, Liu C, Yang X, Zhou Y, Wei X, Ji Q, Yang L, He C. Effects of low-level laser therapy on joint pain, synovitis, anabolic, and catabolic factors in a progressive osteoarthritis rabbit model. Lasers Med Sci. 2014 Nov;29(6):1875-85.

Prianti AC Jr, Silva JA Jr, Dos Santos RF, Rosseti IB, Costa MS. Low-level laser therapy (LLLT) reduces the COX-2 mRNA expression in both subplantar and total brain tissues in the model of peripheral inflammation induced by administration of carrageenan. Lasers Med Sci. 2014 Jul;29(4):1397-403.

Guerra Fda R, Vieira CP, dos Santos de Almeida M, Oliveira LP, Claro AC, Simões GF, de Oliveira AL, Pimentel ER. Pulsed LLLT improves tendon healing in rats: a biochemical, organizational, and functional evaluation. Lasers Med Sci. 2014 Mar;29(2):805-11.

Training and CPD

All laser purchases come with training to enable you to maximise your clinical results from laser use. 

Find out more

Servicing

All our units require regular servicing, our dedicated team of engineers are able to service units at a time convenient for you to ensure your machine remains in top condition.

Find out more 

Free Trial

Celtic SMR is offering free demonstrations and trials of the ASA Laser so please call us on 0800 279 9050 to find out more.

Contact us

Related Products

Get in touch about this item

Our expert team will happily help with any questions you may have.

Please select department
Please select profession
The 'First name' field is required
The 'Last name' field is required
Please enter a valid Email address

Get In Touch

Chat with one of our friendly team members today.